2017至2018年烧伤与吸入性损伤药物治疗相关高影响力文献综述
MeSH检索出1158篇烧伤相关文章,经筛选仅82篇(7%)进入评分,最终全面呈现前10篇;超过半数被评对药物治疗影响有限,提示需更高影响力研究。
要点
- 烧伤/吸入性损伤药物治疗文献分散,多学科团队需系统检索与评价。
- 两年间1158篇烧伤相关文献中仅82篇(7%)进入评分,最终呈现前10篇。
- 超过半数被评文献对药物治疗无显著影响,需更高影响力研究。
核心结论
- 烧伤或吸入性损伤药物治疗相关文献中高影响力研究有限,需更多高质量研究支持临床决策。
主要发现
- 经排除后仅82篇(7%)进入评分,最终全面呈现前10篇。
- 超过半数被评审文稿被评估为对药物治疗缺乏显著影响。
临床怎么用
- 临床药师可参考本综述快速了解2017至2018年烧伤/吸入性损伤药物治疗高影响力文献。
- 提示临床团队在应用相关文献时需注意多数研究对药物治疗影响有限。
局限性
- 仅纳入2017与2018年发表文献,未覆盖其他年份。
- 仅82篇(7%)进入评分,最终仅全面呈现前10篇。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Staying current and evaluating literature related to pharmacotherapy in burn or inhalation injury can be difficult as burn care teams are multidisciplinary and pertinent content can be spread across a plethora of journals. The goal of this review is to critically evaluate recently published pharmacotherapy-pertinent literature, assist practitioners staying current, and better identify potential future research targets. Twelve board-certified clinical pharmacists with experience caring for patients with burn and inhalation injuries reviewed and graded scientific literature published in 2017 and 2018. An MeSH-based search revealed 1158 articles related to burns, which were published during the 2-year period. One-hundred fifty one were determined to be potentially related to pharmacotherapy. After exclusions, only 82 (7%) remained for scoring, and the top 10 comprehensively presented. More than half of the reviewed manuscripts were assessed as lacking a significant impact on pharmacotherapy. There is a need for higher impact literature to support pharmacotherapy-pertinent treatment of such complex patients.
引用
- Hill DM, Pape KO, Zavala S, et al. A Review of the Most Impactful Published Pharmacotherapy-Pertinent Literature of 2017 and 2018 for Clinicians Caring for Patients with Burn or Inhalation Injuries. J Burn Care Res. 2020. PMID: 31400762. doi:10.1093/jbcr/irz138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。